Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
86.65
-0.82 (-0.94%)
At close: Jul 15, 2026, 4:00 PM EDT
87.00
+0.35 (0.40%)
Pre-market: Jul 16, 2026, 5:12 AM EDT
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $5.23 billion as of July 16, 2026. Its market cap has increased by 1,145.16% in one year.
Market Cap
5.23B
Enterprise Value
4.73B
1-Year Change
1,145.16%
Ranking
Category
Stock Price
$86.65
Market Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $5.23B, an increase of 515.32%. That is a compound annual growth rate of 163.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 5.23B | 256.17% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Definium Therapeutics | 6.06B |
| Belite Bio | 5.88B |
| Ligand Pharmaceuticals | 5.87B |
| Dianthus Therapeutics | 5.46B |
| Travere Therapeutics | 5.28B |
| Veradermics | 5.17B |
| CRISPR Therapeutics AG | 5.06B |
| Caris Life Sciences | 4.94B |